{"id":"W3090217457","doi":"10.1158/1078-0432.ccr-20-1693","title":"A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Exemestane; Medicine; Cohort; Breast cancer; Internal medicine; Population; Oncology; Placebo; Adverse effect; Prostate cancer; Clinical endpoint; Metastatic breast cancer; Cancer; Randomized controlled trial; Androgen receptor; Aromatase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002084926,0.00202687,0.003108257,0.0004370819,0.0004934575,0.001143946,0.0009048661,0.001736327,0.008428287],"category_scores_gemma":[0.002532544,0.0007344445,0.001887381,0.0004272036,0.001301683,0.001054711,0.0003903351,0.00300036,0.001148359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007425683,"about_ca_system_score_gemma":0.001553296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006784413,"about_ca_topic_score_gemma":0.00208369,"domain_scores_codex":[0.9990386,0.0005780036,0.00005070814,0.0001770862,0.00005947086,0.00009616751],"domain_scores_gemma":[0.9987587,0.0003554311,0.0003120134,0.0001200402,0.00008564532,0.0003682236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9862515,0.005139299,0.0003195019,0.0002752744,0.000538933,0.00002468025,0.00002233155,0.0001393349,0.001537421,0.00005181649,0.000472472,0.0052273],"study_design_scores_gemma":[0.9701968,0.02858815,0.0005113643,0.00001186579,0.0001649655,0.00001110434,0.00000651966,0.0001058285,0.0001194106,0.00004890893,0.0002304691,0.000004711937],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758412,0.004643848,0.0009811339,0.001112531,0.001120184,0.01091656,0.002350911,0.0001450997,0.002888542],"genre_scores_gemma":[0.973531,0.002684256,0.002198379,0.001858133,0.0008026354,0.01226926,0.002331428,0.00003138509,0.004293488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008428287,"threshold_uncertainty_score":0.02819538,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07947601488622333,"score_gpt":0.467319570512766,"score_spread":0.3878435556265426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}